TEL: +86-21-50180596 Email: sales@biopharmaleader.com

Search

Contact Us

Tel: 0086 21 50180596

Fax: 0086 21 57758967

Mob: 0086 18721201413

E-mail:sales@biopharmaleader.com

Bioactive Molecules

Baricitinib CAS:1187594-09-7

Baricitinib  CAS:1187594-09-7


Product Information

CAS NO.1187594-09-7 2.png
Product NameBaricitinib
SynonymsINCB028050;LY3009104
FormulaC16H17N7O2S
Molecular Weight371.41
Spec / Purity98%min
Supply Capacity
DetailsBaricitinib (INCB28050, LY3009104) is an oral JAK1 and JAK2 inhibitor. Baricitinib is in Phase III development as a potential treatment for rheumatoid arthritis. It is in Phase II development as a potential treatment for psoriasis and diabetic nephropathy. The related compound in JAK inhibitor is Tofacitinib, currently approved for the treatment of rheumatoid arthritis in the United States.

If you are going to consult the information about baricitinib cas:1187594-09-7 from one of the leading Bioactive Molecules manufacturers and suppliers in China, It is always at your service.

Shanghai Biopharmaleader Co.,Ltd